Hims & Hers Taps AI Veteran and Former Cruise President Mo Elshenawy as Chief Technology Officer to Accelerate its AI-Driven Healthcare Vision
Hims & Hers Health, Inc., the rapidly growing digital health platform focused on personalizing care at scale, announced today the appointment of Mo Elshenawy as its new Chief Technology Officer (CTO). Elshenawy, a seasoned technology executive with deep expertise in artificial intelligence (AI), robotics, and large-scale systems infrastructure, brings over 20 years of experience leading engineering and AI teams across some of the world’s most innovative companies. His appointment marks a pivotal step forward for Hims & Hers as it ramps up efforts to transform healthcare delivery through AI-powered solutions.
This leadership addition underscores the company’s long-term vision to build a next-generation digital health platform that blends intelligent diagnostics, personalized treatment plans, and end-to-end virtual care experiences. Hims & Hers is aiming to break down the long-standing barriers to high-quality healthcare—access, affordability, and personalization—by deploying cutting-edge technologies at scale.
A Proven Leader in AI and Scalable Technologies
Mo Elshenawy’s career spans two decades at the forefront of technological innovation. Most recently, he served as President and Chief Technology Officer at Cruise, the autonomous vehicle subsidiary of General Motors. There, he led the company’s technical and operational initiatives during a critical phase of its development, guiding Cruise through regulatory hurdles and scaling the company’s commercial driverless ride-hailing service in San Francisco. Under his leadership, Cruise became one of the first companies to offer a fully driverless experience in a major U.S. city—a major milestone in the mobility sector.
Prior to his role at Cruise, Elshenawy held senior engineering leadership positions at Amazon, where he played a key role in several of the company’s high-impact initiatives. He oversaw global engineering for Amazon’s ReCommerce division and spearheaded the development of retail analytics platforms that generated hundreds of millions of dollars in revenue. His work at Amazon also extended into data science and machine learning systems that enhanced supply chain optimization and customer personalization.
Elshenawy holds more than 10 patents in fields including artificial intelligence, robotics, and autonomous vehicles, underscoring his credentials as both an innovator and a systems thinker. His deep understanding of how to scale AI-driven infrastructure will be instrumental as Hims & Hers looks to expand its digital care offerings and deliver hyper-personalized health services to millions of users across the United States.
Driving an AI-Powered Future of Healthcare
With Elshenawy now at the helm of the company’s technology organization, Hims & Hers plans to accelerate the integration of artificial intelligence into every layer of its digital health platform—from initial symptom intake and triage to diagnosis, treatment recommendation, and delivery logistics.
“The future of care connects diagnosis, treatment, and delivery seamlessly, and in a way that feels tailored to the individual,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “We believe AI is an important way to standardize high-quality care globally to millions of people, regardless of their income or where they live. Our ambition to build a platform that offers access to safe, high-quality, personalized care requires an accelerated investment in technology, and Mo is just the leader to drive that work.”
Dudum emphasized that the company is not just building tools but reshaping the architecture of healthcare delivery to serve people in ways that the traditional system has long failed to provide. According to the company, Elshenawy’s appointment signals a significant commitment to scaling its core capabilities through intelligent automation and data-driven personalization.
A New Healthcare Paradigm
In his own statement, Elshenawy described the company as being on the brink of redefining the way healthcare is accessed and experienced.
“We are standing at the edge of a healthcare revolution, and Hims & Hers is uniquely positioned to lead it,” said Elshenawy. “By harnessing the transformative power of AI and data, we can reimagine how care is delivered—making it more intelligent, more personal, and radically more accessible. I’m honored to join a team that shares this bold vision and is building a next-generation platform designed to serve millions with the precision and empathy every person deserves.”
Elshenawy’s arrival comes at a time when consumer expectations around healthcare are evolving rapidly. People increasingly demand the kind of seamless, on-demand, and customized experiences that they’ve grown accustomed to in other industries like e-commerce and entertainment. Hims & Hers is betting that healthcare will be no different—and that the company’s proactive investments in AI and infrastructure will allow it to become a leader in that transformation.
Strategic Investments in AI and Infrastructure
At the heart of Hims & Hers’ platform is MedMatch, the company’s proprietary intelligent routing system that connects patients to the right clinical services based on symptoms, medical history, and other factors. The company plans to deepen the scope and precision of MedMatch by leveraging more advanced AI models and machine learning techniques under Elshenawy’s guidance.
Hims & Hers also aims to enhance its diagnostic capabilities, allowing clinicians to make faster, more accurate decisions based on real-time data inputs and predictive modeling. These innovations are expected to improve not only efficiency but also clinical outcomes and user satisfaction.
From an operational perspective, the company will continue investing in scalable cloud infrastructure, smart logistics for prescription delivery, and telehealth experiences that feel natural and intuitive. By combining direct-to-consumer infrastructure with intelligent automation, Hims & Hers believes it can dramatically lower the cost of care while expanding access for underserved populations.
Redefining the Patient Experience
More than just a technology upgrade, the company’s ambitions are centered on delivering a superior patient experience. From intake to treatment and follow-up, Hims & Hers wants users to feel supported by a system that understands their unique health needs and adapts accordingly.
This includes personalized treatment plans, seamless follow-ups through digital channels, and data-rich integrations that allow both patients and providers to track progress over time. The company is also exploring ways to integrate wearables, biometric data, and real-time symptom tracking into its platform to provide a more holistic view of health.
Ultimately, the goal is to shift healthcare from reactive to proactive—anticipating needs before they arise and delivering care in a way that is both humane and highly efficient.
Hims & Hers’ bold vision for the future of healthcare is not without its challenges. Building a truly AI-driven healthcare platform requires not only technical expertise but also careful attention to data privacy, clinical oversight, and regulatory compliance. However, with the appointment of a proven leader like Mo Elshenawy, the company is sending a strong signal that it’s ready to meet those challenges head-on.
In the years ahead, Elshenawy will play a critical role in shaping the architecture, ethics, and operational scalability of Hims & Hers’ platform. As the company continues to grow its user base and expand into new treatment categories, the ability to deliver deeply personalized care—at scale and with empathy—will be the ultimate differentiator.
For a company that began by selling telehealth solutions for hair loss and sexual health, Hims & Hers is now staking its claim as a serious innovator in the healthcare technology space. With AI at its core and a world-class CTO now on board, the next chapter in its evolution promises to be one of rapid transformation and impact.
